Matches in SemOpenAlex for { <https://semopenalex.org/work/W1568348519> ?p ?o ?g. }
- W1568348519 endingPage "175" @default.
- W1568348519 startingPage "168" @default.
- W1568348519 abstract "The SPIRIT V (A Clinical Evaluation of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions) study is a post-market surveillance experience of the XIENCE V (Abbott Vascular, Santa Clara, California) everolimus-eluting stent (EES) in patients with higher-risk coronary anatomy.Previous pre-approval studies have shown the safety and efficacy of EES in highly selected groups of patients.The SPIRIT V trial is a prospective, open label, single arm, multicenter study. Two thousand seven hundred patients with multiple de novo coronary artery lesions suitable for treatment with a planned maximum of 4 EES were enrolled at 93 centers in Europe, Asia Pacific, Canada, and South Africa. Lesions had a reference vessel diameter between 2.25 and 4.0 mm and a length of ≤ 28 mm by visual estimation. An independent clinical events committee adjudicated all end point-related events. The primary end point was the composite rate of all death, myocardial infarction (MI), and target vessel revascularization at 30 days. Secondary end points included stent thrombosis and acute success (clinical device and procedure success).At 30 days, the primary composite end point of all death, MI, and target vessel revascularization was 2.7%. At 1 year, rates of cardiac death, overall MI, and target lesion revascularization were 1.1%, 3.5%, and 1.8%, respectively. The cumulative rate of definite and probable stent thrombosis was low at 0.66% at 1 year.Use of EES in patients with multiple, complex de novo lesions yielded 1-year major adverse cardiac events, stent thrombosis, and target lesion revascularization rates that are comparable to those of the more controlled SPIRIT II and SPIRIT III trials-which included patients with restricted inclusion/exclusion criteria-and other all-comer population, physician-initiated studies like the X-SEARCH (Xience Stent Evaluated At Rotterdam Cardiology Hospital) and COMPARE (A Randomized Controlled Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice) trials." @default.
- W1568348519 created "2016-06-24" @default.
- W1568348519 creator A5010743819 @default.
- W1568348519 creator A5012706547 @default.
- W1568348519 creator A5018800965 @default.
- W1568348519 creator A5021686181 @default.
- W1568348519 creator A5037240663 @default.
- W1568348519 creator A5050642494 @default.
- W1568348519 creator A5053058017 @default.
- W1568348519 creator A5053721496 @default.
- W1568348519 creator A5064786072 @default.
- W1568348519 creator A5069456501 @default.
- W1568348519 creator A5079656511 @default.
- W1568348519 date "2011-02-01" @default.
- W1568348519 modified "2023-10-17" @default.
- W1568348519 title "The SPIRIT V Study" @default.
- W1568348519 cites W1959538729 @default.
- W1568348519 cites W1976713371 @default.
- W1568348519 cites W2007747683 @default.
- W1568348519 cites W2009589924 @default.
- W1568348519 cites W2044673637 @default.
- W1568348519 cites W2059830055 @default.
- W1568348519 cites W2087150869 @default.
- W1568348519 cites W2094108113 @default.
- W1568348519 cites W2097373927 @default.
- W1568348519 cites W2106499407 @default.
- W1568348519 cites W2116657535 @default.
- W1568348519 cites W2120754408 @default.
- W1568348519 cites W2125716797 @default.
- W1568348519 doi "https://doi.org/10.1016/j.jcin.2010.11.006" @default.
- W1568348519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21349455" @default.
- W1568348519 hasPublicationYear "2011" @default.
- W1568348519 type Work @default.
- W1568348519 sameAs 1568348519 @default.
- W1568348519 citedByCount "53" @default.
- W1568348519 countsByYear W15683485192012 @default.
- W1568348519 countsByYear W15683485192013 @default.
- W1568348519 countsByYear W15683485192014 @default.
- W1568348519 countsByYear W15683485192015 @default.
- W1568348519 countsByYear W15683485192016 @default.
- W1568348519 countsByYear W15683485192017 @default.
- W1568348519 countsByYear W15683485192018 @default.
- W1568348519 countsByYear W15683485192019 @default.
- W1568348519 countsByYear W15683485192020 @default.
- W1568348519 countsByYear W15683485192021 @default.
- W1568348519 countsByYear W15683485192022 @default.
- W1568348519 countsByYear W15683485192023 @default.
- W1568348519 crossrefType "journal-article" @default.
- W1568348519 hasAuthorship W1568348519A5010743819 @default.
- W1568348519 hasAuthorship W1568348519A5012706547 @default.
- W1568348519 hasAuthorship W1568348519A5018800965 @default.
- W1568348519 hasAuthorship W1568348519A5021686181 @default.
- W1568348519 hasAuthorship W1568348519A5037240663 @default.
- W1568348519 hasAuthorship W1568348519A5050642494 @default.
- W1568348519 hasAuthorship W1568348519A5053058017 @default.
- W1568348519 hasAuthorship W1568348519A5053721496 @default.
- W1568348519 hasAuthorship W1568348519A5064786072 @default.
- W1568348519 hasAuthorship W1568348519A5069456501 @default.
- W1568348519 hasAuthorship W1568348519A5079656511 @default.
- W1568348519 hasConcept C126322002 @default.
- W1568348519 hasConcept C126838900 @default.
- W1568348519 hasConcept C141071460 @default.
- W1568348519 hasConcept C164705383 @default.
- W1568348519 hasConcept C203092338 @default.
- W1568348519 hasConcept C2524010 @default.
- W1568348519 hasConcept C2776820930 @default.
- W1568348519 hasConcept C2778583881 @default.
- W1568348519 hasConcept C2778742706 @default.
- W1568348519 hasConcept C2779464278 @default.
- W1568348519 hasConcept C2779699572 @default.
- W1568348519 hasConcept C2780400711 @default.
- W1568348519 hasConcept C2780868729 @default.
- W1568348519 hasConcept C2781464078 @default.
- W1568348519 hasConcept C2987804222 @default.
- W1568348519 hasConcept C33923547 @default.
- W1568348519 hasConcept C500558357 @default.
- W1568348519 hasConcept C535046627 @default.
- W1568348519 hasConcept C71924100 @default.
- W1568348519 hasConceptScore W1568348519C126322002 @default.
- W1568348519 hasConceptScore W1568348519C126838900 @default.
- W1568348519 hasConceptScore W1568348519C141071460 @default.
- W1568348519 hasConceptScore W1568348519C164705383 @default.
- W1568348519 hasConceptScore W1568348519C203092338 @default.
- W1568348519 hasConceptScore W1568348519C2524010 @default.
- W1568348519 hasConceptScore W1568348519C2776820930 @default.
- W1568348519 hasConceptScore W1568348519C2778583881 @default.
- W1568348519 hasConceptScore W1568348519C2778742706 @default.
- W1568348519 hasConceptScore W1568348519C2779464278 @default.
- W1568348519 hasConceptScore W1568348519C2779699572 @default.
- W1568348519 hasConceptScore W1568348519C2780400711 @default.
- W1568348519 hasConceptScore W1568348519C2780868729 @default.
- W1568348519 hasConceptScore W1568348519C2781464078 @default.
- W1568348519 hasConceptScore W1568348519C2987804222 @default.
- W1568348519 hasConceptScore W1568348519C33923547 @default.
- W1568348519 hasConceptScore W1568348519C500558357 @default.
- W1568348519 hasConceptScore W1568348519C535046627 @default.
- W1568348519 hasConceptScore W1568348519C71924100 @default.
- W1568348519 hasIssue "2" @default.